Adtec Healthcare Limited Revenue

About Adtec Healthcare Limited

Adtec Healthcare Limited is a UK medical device company with innovative cold plasma antibacterial technology for High Unmet Needs. Adtec Plasma kills the Superbugs in proven clinical evidence helping to combat AMR. Efficacy proven in 80+ peer-reviewed clinical studies including 8 RCTs. Early adoption by leading wound care and cardiac surgical infection KOLs. Proven clinical efficacy of infection management , faster and more effective than state of the art = reduced healthcare costs. Unmanaged chronic infected wounds and surgical site infections can lead to serious complications, including repeat surgeries, amputation, prolonged hospital stays, and reduced quality of life for patients. SteriPlas plasma technology is an antibacterial topical treatment with clinical efficacy in treatment of chronic biofilm wound infection, diabetic foot ulcers, post-operative infections (LVAD drivelines, stoma, catheter, deep sternum), and skin conditions such as acne and actinic keratoses. As a topical antibacterial with a physical mode of action, bacterial resistance is unlikely to develop. It can therefore be considered as an alternative therapeutic to antibiotics helping to combat antimicrobial resistance (AMR). New indications planned for post-operative treatment of implants to prevent infection. Plasma is often referred to as the 4th state of matter, the composition of plasma includes heat, OH radicals, ions, electrons, photons, UV light, and reactive species of oxygen and nitrogen. SteriPlas is a CE-marked approved Class IIb medical device with first commercial sales already achieved. Established relations with distributors in 10+ countries in Taiwan, Middle East and Europe. AHL is a spinout standalone medical device company from a leading Japanese semiconductor industrial plasma engineering company and led by a strong management team.

View contact profiles from Adtec Healthcare Limited